The FDA has announced that the distribution of the Johnson & Johnson COVID-19 will be paused after six women in the U.S. had rare blood-clotting after receiving the vaccine. The women were ranging in ages from 18 to 48, and while six people may not seem like a lot precautions are being taken swiftly. There have been approximately 6.8 million shots given with the majority of people not having issues.
The pausing of the Johnson & Johnson vaccine does not affect the other two vaccines from Pfizer and Moderna. But if you did receive the Johnson & Johnson shot and are having to severe stomach pain, leg cramps, or severe headaches you should call your healthcare provider right away. If you do not know what shot you received, check your CDC vaccination card where it is noted what brand shot you received. If you have an appointment scheduled to receive the Johnson & Johnson COVID-19 vaccine, it is advised to call your provider for further directions.
Get Breaking News & Exclusive Contest in Your Inbox:
The Latest:
- Yung Miami Accused of Transporting Drugs For Diddy!!
- Urban One Health and Fitness Expo
- Richelieu Dennis Emerges as ‘Mystery Buyer’ of Diddy’s REVOLT TV Network
- Sixers’ Oubre GOES OFF on Refs After Late Game No-Call
- Premiere: Rudy Currence Gives Glory To God’s Priceless Love In His Music Video For “Ransom”
- ‘Pink Cocaine’: An In-Depth Look at the Expensive and Trendy Drug
- Settlement Reached for Evacuated Tenants of Latitude Five25
- Jazmine Sullivan Returns To Music With A New Fall Tour With Maxwell
- Opal Lee, 97, To Finally Get New Home On Land That White Mob Drove Her Family From 85 Years Ago
- Her Dream Deferred: African American Policy Forum To Shed Light On Issues Impacting Black Women
FDA is Recommending Pausing the Use of Johnson and Johnson Vaccine in the U.S. was originally published on mycolumbusmagic.com